Top of the line genetic sequencing in terms of accuracy, scalability, and affordability51-200 Employees
GenapSys Funding
$249M
66 rounds
GenapSys is active in the following markets / industries: biotechnology, medical, information technology, diagnostics, bioinformatics, genetic testing, software engineering and genomics. The company has secured funding across 6 rounds, totaling in an amount of $249M. Their most recent funding was raised on February 6, 2020.
Funding Rounds
U
$75000000C
$90000000C
$32500000B
$37500000Series BNov 2013
A
$8500000Series AMar 2013
U
$5500000Investors of GenapSys
IPV Capital
Rounds
B
Decheng Capital (德诚资本)
Rounds
A
Foresite Capital
Rounds
C